WuXi XDC Cayman Inc
2268
Rank in Stocks
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Share Price
$8.78
Market Cap
$11.12B
Change (1 day)
-9.52%
Change (1 year)
0.57%
Country
CN
Trade WuXi XDC Cayman Inc (2268)
Category
Healthcare
Dividend history for WuXi XDC Cayman Inc (2268)
WuXi XDC Cayman Inc (stock symbol: 2268) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for WuXi XDC Cayman Inc (2268) from 2026 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 63.00% |
US
|
|
| 137.00% |
US
|
|
| 0.00% |
US
|
|
| 10.00% |
CN
|
|
| 60.00% |
US
|
